Rydell E L, Olofsson J, Hellem S, Axelsson K L
Department of Pharmacology, Faculty of Health Sciences, University of Linköping, Sweden.
Life Sci. 1991;48(10):995-1005. doi: 10.1016/0024-3205(91)90365-i.
Protein phosphorylation was studied in crude and in protein kinase C (Pk-C)-enriched preparations from squamous cell carcinomas and normal mucosa of the human upper aero-digestive tract. In crude soluble preparations from neoplastic mucosa we found a 5-fold higher basal endogenous phosphorylation when compared to normal mucosa. In particulate fractions the increase was 3-fold. SDS-PAGE and autoradiography of phosphorylated proteins in crude soluble tumor extracts showed bands corresponding to proteins with apparent molecular weights of 18, 37, 40-42, 52, 60, 62 and 90 kDa. In normal mucosa the phosphorylation of these proteins was very low or absent, except for the proteins with molecular weights of 40-42 and 52-55 kDa. Addition of Ca2+ or Ca2+/phospholipids to the reaction mixture caused phosphorylation of additional proteins with apparent molecular weight of 45-50 kDa in soluble preparations of tumors. Cyclic AMP or cGMP had no significant effect on the phosphorylation of endogenous proteins. In the partially purified, Pk-C-enriched fractions the phosphorylation in the presence of Ca2+/phospholipids was distinctly higher in tumors when compared to the phosphorylation observed in normal mucosa, and some phosphorylation substrates were detected only in tumor tissue. In order to find out whether the elevated basal phosphorylation was due to an endogenous activation of protein kinases, different inhibitors of serine/threonine protein kinases were tested. These inhibitors included: heat-stable cyclic AMP-dependent protein kinase (Pk-A) inhibitor, Pk-A inhibitor peptide (Wiptide), heparin and the Pk-C inhibitors peptide 19-36 and H-7. None of these inhibitors had any significant effect on the basal phosphorylation. In conclusion, our results show the existence of endogenous phosphorylation substrates in human squamous cell carcinomas from the upper aerodigestive tract, and indicates that there is a significantly higher basal and Pk-C specific phosphorylation of endogenous substrates in tumors compared to normal mucosa. This may be of importance for the transformation and altered growth regulation in epithelial tumors.
对取自人类上呼吸道消化道鳞状细胞癌及正常黏膜的粗提物和富含蛋白激酶C(Pk-C)的制剂中的蛋白质磷酸化进行了研究。在肿瘤黏膜的粗可溶性制剂中,我们发现与正常黏膜相比,基础内源性磷酸化水平高出5倍。在颗粒部分,增加了3倍。肿瘤粗可溶性提取物中磷酸化蛋白的SDS-聚丙烯酰胺凝胶电泳和放射自显影显示出对应于表观分子量为18、37、40 - 42、52、60、62和90 kDa蛋白质的条带。在正常黏膜中,除了分子量为40 - 42和52 - 55 kDa的蛋白质外,这些蛋白质的磷酸化水平非常低或不存在。向反应混合物中添加Ca2+或Ca2+/磷脂会导致肿瘤可溶性制剂中表观分子量为45 - 50 kDa的其他蛋白质发生磷酸化。环磷酸腺苷(cAMP)或环磷酸鸟苷(cGMP)对内源性蛋白质的磷酸化没有显著影响。在部分纯化的富含Pk-C的组分中,与正常黏膜中观察到的磷酸化相比,在Ca2+/磷脂存在下肿瘤中的磷酸化明显更高,并且一些磷酸化底物仅在肿瘤组织中检测到。为了弄清楚基础磷酸化升高是否是由于蛋白激酶的内源性激活,测试了不同的丝氨酸/苏氨酸蛋白激酶抑制剂。这些抑制剂包括:热稳定的环磷酸腺苷依赖性蛋白激酶(Pk-A)抑制剂、Pk-A抑制剂肽(Wiptide)、肝素以及Pk-C抑制剂肽19 - 36和H - 7。这些抑制剂均对基础磷酸化没有任何显著影响。总之,我们的结果表明上呼吸道消化道人类鳞状细胞癌中存在内源性磷酸化底物,并且表明与正常黏膜相比,肿瘤中内源性底物的基础磷酸化和Pk-C特异性磷酸化显著更高。这可能对上呼吸道消化道上皮肿瘤的转化和生长调节改变具有重要意义。